Fri, Aug 29, 2014, 4:41 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

  • granicus007 granicus007 Mar 22, 2013 8:21 AM Flag

    ScientificAmerican excerpts the huge cost and difficulty of bringing "new" drugs to market=resurgence in "old" drugs

    Home » Scientific American Mind » March 2013
    Head Lines | Mind & Brain

    Old Drugs Find New Life as Brain Treatments
    By Daisy Yuhas | March 21, 2013 | 1
    . Share
    Email
    .
    Developing new drugs is no easy feat. As much as 95 percent of new compounds fail along the path to becoming clinically available. Attrition is especially high for drugs treating the central nervous system. The ones that do succeed rack up an average cost of $1.8 billion. So researchers are increasingly turning to the bottles already on the shelf. Proved safe for human consumption and often understood at a molecular level, today's familiar pills might just be tomorrow's medical discovery. Sometimes one man's side effect is another man's cure.

    Sentiment: Strong Buy

 
QCOR
93.600.00(0.00%)Aug 14 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.